chr5-36049107-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_174914.4(UGT3A2):c.625A>G(p.Ser209Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
UGT3A2
NM_174914.4 missense
NM_174914.4 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: -1.08
Genes affected
UGT3A2 (HGNC:27266): (UDP glycosyltransferase family 3 member A2) Enables UDP-glycosyltransferase activity. Acts upstream of or within cellular response to genistein. Predicted to be integral component of membrane. Predicted to be active in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UGT3A2 | NM_174914.4 | c.625A>G | p.Ser209Gly | missense_variant | 4/7 | ENST00000282507.8 | NP_777574.2 | |
UGT3A2 | NM_001168316.2 | c.523A>G | p.Ser175Gly | missense_variant | 3/6 | NP_001161788.1 | ||
UGT3A2 | XM_011513988.2 | c.706A>G | p.Ser236Gly | missense_variant | 5/8 | XP_011512290.1 | ||
UGT3A2 | NR_031764.2 | n.404+2763A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UGT3A2 | ENST00000282507.8 | c.625A>G | p.Ser209Gly | missense_variant | 4/7 | 1 | NM_174914.4 | ENSP00000282507 | P1 | |
UGT3A2 | ENST00000513300.5 | c.523A>G | p.Ser175Gly | missense_variant | 3/6 | 2 | ENSP00000427404 | |||
UGT3A2 | ENST00000504685.5 | c.311+2763A>G | intron_variant, NMD_transcript_variant | 2 | ENSP00000426017 | |||||
UGT3A2 | ENST00000504954.1 | n.494+2763A>G | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2022 | The c.625A>G (p.S209G) alteration is located in exon 4 (coding exon 4) of the UGT3A2 gene. This alteration results from a A to G substitution at nucleotide position 625, causing the serine (S) at amino acid position 209 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MutPred
Loss of sheet (P = 0.0011);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -11
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.